Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We studied eight patients with combined resting-postural tremors, which are classified as a subtype of essential
tremor
.
Trihexyphenidyl hydrochloride
, levodopa, and propranolol hydrochloride therapy were not effective in reducing these tremors.
...
PMID:Combined resting-postural tremors. 401 65
2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.178) deficiency is a recently described defect of isoleucine catabolism. The disorder is characterized by normal early development followed by a progressive loss of mental and motor skills. Deterioration may be rapid or may follow a slower decline with a possible stabilization of the disorder on a low-protein diet and appropriate medication. We report a 23-year-old man with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency with a very mild clinical course. He had apparently normal early development and remained relatively well until the age of 6 years, when he contracted measles. Following this illness, his motor skills and school progress deteriorated. At 15 years he had significant dysarthria, and generalized rigidity with some dystonic and unusual posturing. He was then treated with a low-protein high-carbohydrate diet with a good response in terms of balance and gait. At 18 years he was given benzhexol (
Artane
), increased slowly from 2 mg to 6 mg daily, resulting in improvement in
tremor
and dystonia. At 23 years he can dress himself and works in sheltered employment but remains severely dysarthric.
...
PMID:2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man. 1255 40